Identification, Functional Characterization, and Pathobiological Significance of GLI1 Isoforms in Human Cancers

Vitamins and Hormones

Volumn 88, Issue , 2012, Pages 115-140

  Carpenter, Richard L ^a   Lo, Hui Wen ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE CANCER INSTITUTE   (United States)

Author keywords

GLI1; GLI1 N; GLI2; Sonic Hedgehog; TGF ; TGLI1; VEGF A

Indexed keywords

EID: 84857700991     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394622-5.00006-7     Document Type: Chapter

References (93)

1. Abe Y., Oda-Sato E., Tobiume K., Kawauchi K., Taya Y., Okamoto K., Oren M., Tanaka N. Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2. Proc. Natl. Acad. Sci. USA 2008, 105:4838-4843.
2. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100:3983-3988.
3. Arheden K., Ronne M., Mandahl N., Heim S., Kinzler K.W., Vogelstein B., Mitelman F. In situ hybridization localizes the human putative oncogene GLI to chromosome subbands 12q13.3-14.1. Hum. Genet. 1989, 82:1-2.
4. Baumann P., Cremers N., Kroese F., Orend G., Chiquet-Ehrismann R., Uede T., Yagita H., Sleeman J.P. CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res. 2005, 65:10783-10793.
5. Bergers G., Benjamin L.E. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 2003, 3:401-410.
6. Bigner S.H., Wong A.J., Mark J., Muhlbaier L.H., Kinzler K.W., Vogelstein B., Bigner D.D. Relationship between gene amplification and chromosomal deviations in malignant human gliomas. Cancer Genet. Cytogenet. 1987, 29:165-170.
7. Cai Q., Li J., Gao T., Xie J., Evers B.M. Protein kinase Cδ negatively regulates Hedgehog signaling by inhibition of Gli1 activity. J. Biol. Chem. 2009, 284:2150-2158.
8. Cao X., Geradts J., Dewhirst M.W., Lo H.W. Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells. Oncogene 2012, 31:104-115.
9. Chen J.K., Taipale J., Young K.E., Maiti T., Beachy P.A. Small molecule modulation of Smoothened activity. Proc. Natl. Acad. Sci. USA 2002, 99:14071-14076.
10. Clement V., Sanchez P., de Tribolet N., Radovanovic I., Ruiz i Altaba A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol. 2007, 17:165-172.
11. Cui D., Xu Q., Wang K., Che X. Gli1 is a potential target for alleviating multidrug resistance of gliomas. J. Neurol. Sci. 2010, 288:156-166.
12. Dahmane N., Sanchez P., Gitton Y., Palma V., Sun T., Beyna M., Weiner H., Ruiz i Altaba A. The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development 2001, 128:5201-5212.
13. Das S., Harris L.G., Metge B.J., Liu S., Riker A.I., Samant R.S., Shevde L.A. The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating osteopontin. J. Biol. Chem. 2009, 284:22888-22897.
14. Dennler S., Andre J., Alexaki I., Li A., Magnaldo T., ten Dijke P., Wang X.J., Verrecchia F., Mauviel A. Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res. 2007, 67:6981-6986.
15. Dennler S., André J., Verrecchia F., Mauviel A. Cloning of the human GLI2 promoter. J. Biol. Chem. 2009, 284:31523-31531.
16. Dunaeva M., Michelson P., Kogerman P., Toftgard R. Characterization of the physical interaction of Gli proteins with SUFU proteins. J. Biol. Chem. 2003, 278:5116-5122.
17. Epstein D.J., Marti E., Scott M.P., McMahon A.P. Antagonizing cAMP-dependent protein kinase A in the dorsal CNS activates a conserved Sonic hedgehog signaling pathway. Development 1996, 122:2885-2894.
18. Fiaschi M., Rozell B., Bergstrom A., Toftgard R. Development of mammary tumors by conditional expression of GLI1. Cancer Res. 2009, 69:4810-4817.
19. Forus A., Florenes V.A., Maelandsmo G.M., Meltzer P.S., Fodstad O., Myklebost O. Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: Some amplica do not include MDM2. Cell Growth Differ. 1993, 4:1065-1070.
20. Gordon A.T., Brinkschmidt C., Anderson J., Coleman N., Dockhorn-Dworniczak B., Pritchard-Jones K., Shipley J. A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 2000, 28:220-226.
21. Hsieh A., Ellsworth R., Hsieh D. Hedgehog/GLI1 regulates IGF dependent malignant behaviors in glioma stem cells. J. Cell. Physiol. 2011, 226:1118-1127.
22. Huang S., He J., Zhang X., Bian Y., Yang L., Xie G., Zhang K., Tang W., Stelter A.A., Wang Q., Zhang H., Xie J. Activation of the hedgehog pathway in human hepatocellular carcinomas. Carcinogenesis 2006, 27:1334-1340.
23. Huntzicker E.G., Estay I.S., Zhen H., Lokteva L.A., Jackson P.K., Oro A.E. Dual degradation signals control Gli protein stability and tumor formation. Genes Dev. 2006, 20:276-281.
24. Hynes M., Stone D.M., Dowd M., Pitts-Meek S., Goddard A., Gurney A., Rosenthal A. Control of cell pattern in the neural tube by the zinc finger transcription factor and oncogene Gli-1. Neuron 1997, 19:15-26.
25. Ingham P.W., McMahon A.P. Hedgehog signaling in animal development: Paradigms and principles. Genes Dev. 2001, 15:3059-3087.
26. Ingham P.W., Nakano Y., Seger C. Mechanisms and functions of Hedgehog signalling across the metazoa. Nat. Rev. Genet. 2011, 12:393-406.
27. Ji Z., Mei F.C., Xie J., Cheng X. Oncogenic KRAS activates Hedgehog signaling pathway in pancreatic cancer cells. J. Biol. Chem. 2007, 282:14048-14055.
28. Jiang J., Struhl G. Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb. Nature 1998, 391:493-496.
29. Kang S., Graham J.M., Olney A.H., Biesecker L.G. GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nat. Genet. 1997, 15:266-268.
30. Kasper M., Regl G., Frischauf A.M., Aberger F. GLI transcription factors: Mediators of oncogenic Hedgehog signalling. Eur. J. Cancer 2006, 42:437-445.
31. Keysar S.B., Jimeno A. More than markers: Biological significance of cancer stem cell-defining molecules. Mol. Cancer Ther. 2010, 9:2450-2457.
32. Kim H.J., Kim J.B., Lee K.M., Shin I., Han W., Ko E., Bae J.Y., Noh D.Y. Isolation of CD24(high) and CD24(low/-) cells from MCF-7: CD24 expression is positively related with proliferation, adhesion and invasion in MCF-7. Cancer Lett. 2007, 258:98-108.
33. Kimura H., Stephen D., Joyner A., Curran T. Gli1 is important for medulloblastoma formation in Ptc1+/- mice. Oncogene 2005, 24:4026-4036.
34. Kinzler K.W., Vogelstein B. The GLI gene encodes a nuclear protein which binds specific sequences in the human genome. Mol. Cell. Biol. 1990, 10:634-642.
35. Kinzler K.W., Bigner S.H., Bigner D.D., Trent J.M., Law M.L., O'Brien S.J., Wong A.J., Vogelstein B. Identification of an amplified, highly expressed gene in a human glioma. Science 1987, 236:70-73.
36. Kinzler K.W., Ruppert J.M., Bigner S.H., Vogelstein B. The GLI gene is a member of the Kruppel family of zinc finger proteins. Nature 1988, 332:371-374.
37. Kogerman P., Grimm T., Kogerman L., Krause D., Unden A.B., Sandstedt B., Toftgard R., Zaphiropoulos P.G. Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1. Nat. Cell Biol. 1999, 1:312-319.
38. Kristiansen G., Winzer K.J., Mayordomo E., Bellach J., Schluns K., Denkert C., Dahl E., Pilarsky C., Altevogt P., Guski H., Dietel M. CD24 expression is a new prognostic marker in breast cancer. Clin. Cancer Res. 2003, 9:4906-4913.
39. Lee J., Platt K.A., Censullo P., Ruiz i Altaba A. Gli1 is a target of Sonic hedgehog that induces ventral neural tube development. Development 1997, 124:2537-2552.
40. Lee J.H., Kim S.H., Lee E.S., Kim Y.S. CD24 overexpression in cancer development and progression: A meta-analysis. Oncol. Rep. 2009, 22:1149-1156.
41. Li X., Deng W., Nail C.D., Bailey S.K., Kraus M.H., Ruppert J.M., Lobo-Ruppert S.M. Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation. Oncogene 2006, 25:609-621.
42. Li C., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V., Wicha M., Clarke M.F., Simeone D.M. Identification of pancreatic cancer stem cells. Cancer Res. 2007, 67:1030-1037.
43. Liao X., Siu M.K., Au C.W., Wong E.S., Chan H.Y., Ip P.P., Ngan H.Y., Cheung A.N. Aberrant activation of hedgehog signaling pathway in ovarian cancers: Effect on prognosis, cell invasion and differentiation. Carcinogenesis 2009, 30:131-140.
44. Liu S., Dontu G., Mantle I.D., Patel S., Ahn N.S., Jackson K.W., Suri P., Wicha M.S. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 2006, 66:6063-6071.
45. Lo H.W., Hsu S.C., Xia W., Cao X., Shih J.Y., Wei Y., Abbruzzese J.L., Hortobagyi G.N., Hung M.C. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res. 2007, 67:9066-9076.
46. Lo H.W., Zhu H., Cao X., Aldrich A., Ali-Osman F. A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion. Cancer Res. 2009, 69:6790-6798.
47. LoRusso P.M., Rudin C.M., Borad M.J., Vernillet L., Darbonne W.C., Mackey H., DiMartino J.F., de Sauvage F., Low J.A., Von Hoff D.D. A first-in-human, first-in-class, phase (ph) I study of systemic Hedgehog (Hh) pathway antagonist, GDC-0449, in patients (pts) with advanced solid tumors. J. Clin. Oncol. 2008, 26:3516. (Meeting Abstracts).
48. Louro I.D., Bailey E.C., Li X., South L.S., McKie-Bell P.R., Yoder B.K., Huang C.C., Johnson M.R., Hill A.E., Johnson R.L., Ruppert J.M. Comparative gene expression profile analysis of GLI and c-MYC in an epithelial model of malignant transformation. Cancer Res. 2002, 62:5867-5873.
49. Lum L., Beachy P.A. The Hedgehog response network: Sensors, switches, and routers. Science 2004, 304:1755-1759.
50. Ma X., Chen K., Huang S., Zhang X., Adegboyega P.A., Evers B.M., Zhang H., Xie J. Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis 2005, 26:1698-1705.
51. Ma X., Sheng T., Zhang Y., Zhang X., He J., Huang S., Chen K., Sultz J., Adegboyega P.A., Zhang H., Xie J. Hedgehog signaling is activated in subsets of esophageal cancers. Int. J. Cancer 2006, 118:139-148.
52. Mao J., Maye P., Kogerman P., Tejedor F.J., Toftgard R., Xie W., Wu G., Wu D. Regulation of Gli1 transcriptional activity in the nucleus by Dyrk1. J. Biol. Chem. 2002, 277:35156-35161.
53. Meyer M.J., Fleming J.M., Lin A.F., Hussnain S.A., Ginsburg E., Vonderhaar B.K. CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer. Cancer Res. 2010, 70:4624-4633.
54. Nakamura K., Sasajima J., Mizukami Y., Sugiyama Y., Yamazaki M., Fujii R., Kawamoto T., Koizumi K., Sato K., Fujiya M., Sasaki K., Tanno S., et al. Hedgehog promotes neovascularization in pancreatic cancers by regulating Ang-1 and IGF-1 expression in bone-marrow derived pro-angiogenic cells. PLoS One 2010, 5:e8824.
55. Neill G.W., Harrison W.J., Ikram M.S., Williams T.D., Bianchi L.S., Nadendla S.K., Green J.L., Ghali L., Frischauf A.M., O'Toole E.A., Aberger F., Philpott M.P. GLI1 repression of ERK activity correlates with colony formation and impaired migration in human epidermal keratinocytes. Carcinogenesis 2008, 29:738-746.
56. Ng J.M., Curran T. The Hedgehog's tale: Developing strategies for targeting cancer. Nat. Rev. Cancer 2011, 11:493-501.
57. Nolan-Stevaux O., Lau J., Truitt M.L., Chu G.C., Hebrok M., Fernandez-Zapico M.E., Hanahan D. GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev. 2009, 23:24-36.
58. Oka N., Soeda A., Inagaki A., Onodera M., Maruyama H., Hara A., Kunisada T., Mori H., Iwama T. VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells. Biochem. Biophys. Res. Commun. 2007, 360:553-559.
59. Pathi S., Pagan-Westphal S., Baker D.P., Garber E.A., Rayhorn P., Bumcrot D., Tabin C.J., Blake Pepinsky R., Williams K.P. Comparative biological responses to human Sonic, Indian, and Desert hedgehog. Mech. Dev. 2001, 106:107-117.
60. Pavletich N.P., Pabo C.O. Crystal structure of a five-finger GLI-DNA complex: New perspectives on zinc fingers. Science 1993, 261:1701-1707.
61. Radhakrishna U., Wild A., Grzeschik K.H., Antonarakis S.E. Mutation in GLI3 in postaxial polydactyly type A. Nat. Genet. 1997, 17:269-271.
62. Raffel C., Jenkins R.B., Frederick L., Hebrink D., Alderete B., Fults D.W., James C.D. Sporadic medulloblastomas contain PTCH mutations. Cancer Res. 1997, 57:842-845.
63. Rao S.K., Edwards J., Joshi A.D., Siu I.M., Riggins G.J. A survey of glioblastoma genomic amplifications and deletions. J. Neurooncol. 2010, 96(2):169-179.
64. Reifenberger G., Reifenberger J., Ichimura K., Meltzer P.S., Collins V.P. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: Preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res. 1994, 54:4299-4303.
65. Ricci-Vitiani L., Pallini R., Biffoni M., Todaro M., Invernici G., Cenci T., Maira G., Parati E.A., Stassi G., Larocca L.M., De Maria R. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 2010, 468:824-828.
66. Riobo N.A., Lu K., Ai X., Haines G.M., Emerson C.P. Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling. Proc. Natl. Acad. Sci. USA 2006, 103:4505-4510.
67. Roberts W.M., Douglass E.C., Peiper S.C., Houghton P.J., Look A.T. Amplification of the gli gene in childhood sarcomas. Cancer Res. 1989, 49:5407-5413.
68. Roessler E., Belloni E., Gaudenz K., Jay P., Berta P., Scherer S.W., Tsui L.C., Muenke M. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat. Genet. 1996, 14:357-360.
69. Rudin C.M., Hann C.L., Laterra J., Yauch R.L., Callahan C.A., Fu L., Holcomb T., Stinson J., Gould S.E., Coleman B., LoRusso P.M., Von Hoff D.D., et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N. Engl. J. Med. 2009, 361:1173-1178.
70. Runz S., Mierke C.T., Joumaa S., Behrens J., Fabry B., Altevogt P. CD24 induces localization of beta1 integrin to lipid raft domains. Biochem. Biophys. Res. Commun. 2008, 365:35-41.
71. Sasaki H., Hui C., Nakafuku M., Kondoh H. A binding site for Gli proteins is essential for HNF-3beta floor plate enhancer activity in transgenics and can respond to Shh in vitro. Development 1997, 124:1313-1322.
72. Schreck K.C., Taylor P., Marchionni L., Gopalakrishnan V., Bar E.E., Gaiano N., Eberhart C.G. The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: A potential mechanism of therapeutic resistance. Clin. Cancer Res. 2010, 16:6060-6070.
73. Seto M., Ohta M., Asaoka Y., Ikenoue T., Tada M., Miyabayashi K., Mohri D., Tanaka Y., Ijichi H., Tateishi K., Kanai F., Kawabe T., et al. Regulation of the hedgehog signaling by the mitogen-activated protein kinase cascade in gastric cancer. Mol. Carcinog. 2009, 48:703-712.
74. Sheng T., Li C., Zhang X., Chi S., He N., Chen K., McCormick F., Gatalica Z., Xie J. Activation of the hedgehog pathway in advanced prostate cancer. Mol. Cancer 2004, 3:29.
75. Sheng T., Chi S., Zhang X., Xie J. Regulation of Gli1 localization by the cAMP/protein kinase A signaling axis through a site near the nuclear localization signal. J. Biol. Chem. 2006, 281:9-12.
76. Shimokawa T., Tostar U., Lauth M., Palaniswamy R., Kasper M., Toftgard R., Zaphiropoulos P.G. Novel human glioma-associated oncogene 1 (GLI1) splice variants reveal distinct mechanisms in the terminal transduction of the hedgehog signal. J. Biol. Chem. 2008, 283:14345-14354.
77. Stecca B., Ruiz i Altaba A. A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. EMBO J. 2009, 28:663-676.
78. Stecca B., Mas C., Clement V., Zbinden M., Correa R., Piguet V., Beermann F., Ruiz I.A.A. Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proc. Natl. Acad. Sci. USA 2007, 104:5895-5900.
79. Stein U., Eder C., Karsten U., Haensch W., Walther W., Schlag P.M. GLI gene expression in bone and soft tissue sarcomas of adult patients correlates with tumor grade. Cancer Res. 1999, 59:1890-1895.
80. Taylor M.D., Liu L., Raffel C., Hui C.C., Mainprize T.G., Zhang X., Agatep R., Chiappa S., Gao L., Lowrance A., Hao A., Goldstein A.M., et al. Mutations in SUFU predispose to medulloblastoma. Nat. Genet. 2002, 31:306-310.
81. ten Haaf A., Bektas N., von Serenyi S., Losen I., Arweiler E., Hartmann A., Knuchel R., Dahl E. Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival. BMC Cancer 2009, 9:298.
82. Thomas Z.I., Gibson W., Sexton J.Z., Aird K.M., Ingram S.M., Aldrich A., Lyerly H.K., Devi G.R., Williams K.P. Targeting GLI1 expression in human inflammatory breast cancer cells enhances apoptosis and attenuates migration. Br. J. Cancer 2011, 104:1575-1586.
83. Villavicencio E.H., Walterhouse D.O., Iannaccone P.M. The sonic hedgehog-patched-gli pathway in human development and disease. Am. J. Hum. Genet. 2000, 67:1047-1054.
84. Von Hoff D.D., LoRusso P.M., Rudin C.M., Reddy J.C., Yauch R.L., Tibes R., Weiss G.J., Borad M.J., Hann C.L., Brahmer J.R., Mackey H.M., Lum B.L., et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N. Engl. J. Med. 2009, 361:1164-1172.
85. Wang G., Zhang Z., Xu Z., Yin H., Bai L., Ma Z., Decoster M.A., Qian G., Wu G. Activation of the sonic hedgehog signaling controls human pulmonary arterial smooth muscle cell proliferation in response to hypoxia. Biochim. Biophys. Acta 2010, 1803:1359-1367.
86. Wong A.J., Bigner S.H., Bigner D.D., Kinzler K.W., Hamilton S.R., Vogelstein B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc. Natl. Acad. Sci. USA 1987, 84:6899-6903.
87. Xie J., Murone M., Luoh S.M., Ryan A., Gu Q., Zhang C., Bonifas J.M., Lam C.W., Hynes M., Goddard A., Rosenthal A., Epstein E.H., et al. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 1998, 391:90-92.
88. Xie J., Aszterbaum M., Zhang X., Bonifas J.M., Zachary C., Epstein E., McCormick F. A role of PDGFRα in basal cell carcinoma proliferation. Proc. Natl. Acad. Sci. USA 2001, 98:9255-9259.
89. Xu L., Kwon Y.-J., Frolova N., Steg A., Yuan K., Johnson M., Grizzle W., Desmond R., Frost A. Gli1 promotes cell survival and is predictive of a poor outcome in ERα-negative breast cancer. Breast Cancer Res. Treat. 2010, 123:59-71.
90. Yang L., Xie G., Fan Q., Xie J. Activation of the hedgehog-signaling pathway in human cancer and the clinical implications. Oncogene 2010, 29:469-481.
91. Yoon J.W., Kita Y., Frank D.J., Majewski R.R., Konicek B.A., Nobrega M.A., Jacob H., Walterhouse D., Iannaccone P. Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J. Biol. Chem. 2002, 277:5548-5555.
92. Zbinden M., Duquet A., Lorente-Trigos A., Ngwabyt S.N., Borges I., Ruiz i Altaba A. NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. EMBO J. 2010, 29:2659-2674.
93. Zhu H., Lo H.-W. The human glioma-associated oncogene homolog 1 (GLI1) family of transcription factors in gene regulation and diseases. Curr. Genomics 2010, 11:238-245.